Actively Recruiting
Early STratification of Acute ARThritis (START) - A Prospective Observational Study
Led by Diakonhjemmet Hospital · Updated on 2025-08-06
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
D
Diakonhjemmet Hospital
Lead Sponsor
O
Oslo University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting the Early STratification of acute inflammatory ARThritis (START) study, a prospective observational study focused on early-stage inflammatory arthritis. The study aims to identify markers that can help with early diagnosis and personalized treatment of various inflammatory joint conditions. It addresses the challenge of managing early arthritis by using advanced methods to better understand the disease and improve patient care. The project is sponsored by Diakonhjemmet Hospital. The study does not involve any treatment or intervention. Instead, it collects extensive data from participants using modern imaging techniques, analyses of synovial fluid and biopsies, and studies of genetic, epigenetic, proteomic, microbiota, and immunological markers. This comprehensive approach seeks to build a platform to identify and validate biomarkers for better stratification of early inflammatory arthritis. Participants will be followed for 12 months to determine the final diagnosis. During this time, researchers will gather clinical data and conduct multiple assessments to monitor disease progression and biomarker relevance. The goal is to provide clinicians with improved tools for timely diagnosis and personalized care decisions. The total duration of participation spans at least one year, with regular evaluations to support study outcomes.
CONDITIONS
Brief Title
Early STratification of Acute ARThritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Arthritis in one or more joints for less than 12 weeks
- Adult patients over 18 years old able to understand and sign consent
- At least one swollen joint currently active, confirmed by an expert or ultrasound
You will not qualify if you...
- Swollen joint caused by trauma
- Unable to follow the study procedures or protocol requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 weeks
Participants undergo assessments to determine the cause and characteristics of arthritis.
1 to 2 visits depending on assessments
Duration - 12 months
Participants are observed over time to monitor disease progression and final diagnosis.
Periodic visits over 12 months
Trial Site Locations
Total: 1 location
1
Diakonhjemmet Hospital
Oslo, Norway, 0319
Actively Recruiting
Research Team
S
Silje W Syversen, MD PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here